MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Monday revealed new animal study results from SKNY-1, a next-generation oral ...

The drug also made the animals less likely to pursue food in stressful ... "These results highlight SKNY-1's potential to address both obesity and nicotine addiction through unique and safe pathways." ...

For people recovering from substance use disorders, quitting smoking remains one of the most difficult-but most crucial-steps ...

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone ...

While vapes provide a far healthier alternative to cigarettes, there are concerns that vaping provides a gateway into ...

E-cigarettes have become increasingly popular over the last two decades, especially among young people. These sleek, ...

Some people with long COVID are turning to an unlikely remedy: nicotine gum and patches. Though typically used to quit ...

And over the past several years, they’ve skyrocketed in popularity.

Achieve Life Sciences, Inc. has submitted a New Drug Application (NDA) to the U.S. FDA for cytisinicline, which, if approved, would be the first new pharmacotherapy for nicotine dependence in 20 ...

Some pediatric doctors in the metro Atlanta area say they’re alarmed by the soaring use of nicotine pouches by teens. The ...

Utah Gov. Spencer Cox, Utah Attorney General Derek Brown, and the Utah Department of Commerce’s Margaret Busse filed a lawsuit against Snap, Inc.The lawsuit all ...

Achieve Life Sciences is partnering with marketing company Omnicom to lead Achieve's commercial launch of a potential new treatment for nicotine dependence in the U.S. The pharmaceutical company on ...